Search research articles
Contact Us
Filters
Showing results (331-340 of 415) with videos related to
Page
of 42
Sort By:
Open Forum Infectious Diseases
|
July 16, 2019
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland
Galia M A Santos, Isabella Locatelli, Mélanie Métral, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 8, 2020
Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors
Elisabeth Deutschmann, Heiner C Bucher, Steffen Jaeckel, et al.
Vaccines
|
August 26, 2023
SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients
Natacha Bordry, Anne-Claire Mamez, Chiara Fedeli, et al.
Antiviral Therapy
|
April 3, 2020
Differences in social and mental well-being of long-term survivors among people who inject drugs and other participants in the Swiss HIV Cohort Study: 1980-2018
Katharina Kusejko, Alex Marzel, Huyen Nguyen, et al.
AIDS (London, England)
|
August 19, 2021
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
José Damas, Bruno Ledergerber, Isaure Nadin, et al.
HIV Medicine
|
October 18, 2023
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023
Juan Ambrosioni, Laura Levi, Jasmini Alagaratnam, et al.
BMC Infectious Diseases
|
June 30, 2012
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
Alexandra Calmy, Eric Balestre, Fabrice Bonnet, et al.
Open Forum Infectious Diseases
|
December 29, 2023
Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study
Mireille Mpoudi-Etame, Tamara Tovar Sanchez, Marwân-Al-Qays Bousmah, et al.
International Journal of STD & AIDS
|
February 25, 2021
The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland
Galia Santos, Isabella Locatelli, Mélanie Métral, et al.
Tropical Medicine & International Health : TM & IH
|
July 22, 2025
High Burden of Symptomatic and Asymptomatic Sexually Transmitted Infections in a Routine Decentralised HIV Care Setting in Eswatini: A Cross-Sectional Study
Bernhard Kerschberger, Nombuso Ntshalintshali, Mano Isaac Mafomisa, et al.
Page
of 42
Search research articles
Search
Showing results (331-340 of 415) with videos related to
Sort By:
Page
of 42
Open Forum Infectious Diseases
|
July 16, 2019
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland
Galia M A Santos, Isabella Locatelli, Mélanie Métral, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 8, 2020
Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors
Elisabeth Deutschmann, Heiner C Bucher, Steffen Jaeckel, et al.
Vaccines
|
August 26, 2023
SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients
Natacha Bordry, Anne-Claire Mamez, Chiara Fedeli, et al.
Antiviral Therapy
|
April 3, 2020
Differences in social and mental well-being of long-term survivors among people who inject drugs and other participants in the Swiss HIV Cohort Study: 1980-2018
Katharina Kusejko, Alex Marzel, Huyen Nguyen, et al.
AIDS (London, England)
|
August 19, 2021
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
José Damas, Bruno Ledergerber, Isaure Nadin, et al.
HIV Medicine
|
October 18, 2023
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023
Juan Ambrosioni, Laura Levi, Jasmini Alagaratnam, et al.
BMC Infectious Diseases
|
June 30, 2012
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
Alexandra Calmy, Eric Balestre, Fabrice Bonnet, et al.
Open Forum Infectious Diseases
|
December 29, 2023
Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study
Mireille Mpoudi-Etame, Tamara Tovar Sanchez, Marwân-Al-Qays Bousmah, et al.
International Journal of STD & AIDS
|
February 25, 2021
The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland
Galia Santos, Isabella Locatelli, Mélanie Métral, et al.
Tropical Medicine & International Health : TM & IH
|
July 22, 2025
High Burden of Symptomatic and Asymptomatic Sexually Transmitted Infections in a Routine Decentralised HIV Care Setting in Eswatini: A Cross-Sectional Study
Bernhard Kerschberger, Nombuso Ntshalintshali, Mano Isaac Mafomisa, et al.
Page
of 42